Choose a preparation by the biology and time the question requires, then verify its actual components and endpoint.
Conventional xenografts, epithelial organoids and short-term fragments make different trade-offs. Xenografts add a living host with mouse support and exposure. Organoids expand selected populations in supplied culture conditions. Fragments can retain local neighbours briefly without perfused circulation. This comparison describes preparations and decision windows; the existing model-context framework owns the broader question of intended-use validation.
Showing the technology this term belongs to: Patient-derived xenografts.
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
Shares Patient-derived xenografts, Functional (ex vivo) drug testing.
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/